Number of the records: 1
Formation of gadolinium-ferritin from clinical magnetic resonance contrast agents
- 1.
SYSNO ASEP 0537034 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title Formation of gadolinium-ferritin from clinical magnetic resonance contrast agents Author(s) Neburková, Jitka (UOCHB-X) RID, ORCID
Rulseh, A. M. (CZ)
Chang, S. L. Y. (AU)
Raabová, Helena (UOCHB-X)
Vejpravová, J. (CZ)
Dračínský, Martin (UOCHB-X) RID, ORCID
Tarábek, Ján (UOCHB-X) RID, ORCID
Kotek, J. (CZ)
Pingle, M. (CZ)
Majer, Pavel (UOCHB-X)
Vymazal, J. (CZ)
Cígler, Petr (UOCHB-X) RID, ORCIDSource Title Nanoscale Advances. - : Royal Society of Chemistry - ISSN 2516-0230
Roč. 2, č. 12 (2020), s. 5567-5571Number of pages 5 s. Language eng - English Country GB - United Kingdom Keywords nephrogenic systemic fibrosis ; high signal intensity ; dentate nucleus Subject RIV CD - Macromolecular Chemistry OECD category Nano-materials (production and properties) R&D Projects EF16_019/0000729 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) Method of publishing Open access Institutional support UOCHB-X - RVO:61388963 UT WOS 000599127600006 EID SCOPUS 85097958025 DOI 10.1039/c9na00567f Annotation Gadolinium deposition in the brain following administration of gadolinium-based contrast agents (GBCAs) has led to health concerns. We show that some clinical GBCAs form Gd3+-ferritin nanoparticles at (sub)nanomolar concentrations of Gd3+ under physiological conditions. We describe their structure at atomic resolution and discuss potential relevance for clinical MRI. Workplace Institute of Organic Chemistry and Biochemistry Contact asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418 Year of Publishing 2021 Electronic address https://doi.org/10.1039/C9NA00567F
Number of the records: 1